Controversies related to renal artery denervation and devices

被引：0

作者：

Agwuegbo, Chibuike Charles ^{[1
]}

Antia, Akanimo Usen ^{[2
]}

Shamaki, Garba Rimamskep ^{[3
]}

Bob-Manuel, Tamunoinemi ^{[4
]}

机构：

[1] Southwest Healthcare, Dept Med, Temecula, CA 92590 USA

[2] Lincoln Med Ctr, Dept Med, Bronx, NY USA

[3] Rochester Reg Hosp, Unity Hosp, Dept Med, Rochester, NY USA

[4] Univ Tennessee, Hlth Sci Ctr, Div Cardiovasc Dis, Memphis, TN USA

来源：

CURRENT OPINION IN CARDIOLOGY | 2024年 / 39卷 / 04期

关键词：

renal artery ablation; renal artery denervation; renal denervation; resistant hypertension; RESISTANT HYPERTENSION; TRIAL; EFFICACY; SAFETY;

D O I：

10.1097/HCO.0000000000001146

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Purpose of reviewThis review article discusses the controversies, strengths, and limitations of the current literature on renal artery denervation in the management of resistant hypertension, as well as the future directions of this intervention.Recent findingsThere have been conflicting data from the different randomized control trials assessing the efficacy of renal artery denervation in the management of resistant hypertension.SummaryRenal artery denervation is achieved by ablating the sympathetic nerves surrounding the renal arteries using endovascular ultrasound, radiofrequency, or alcohol. Our review article highlights that renal artery denervation is generally effective in improving blood pressure in patients with resistant hypertension. The Food and Drug Administration (FDA) has recently approved the ReCor Medical Paradise system, and the Symplicity Spyral RDN systems for renal artery denervation.

引用

页码：244 / 250

页数：7

共 37 条

[1] [Anonymous], 2023, Facts about hypertension CdC.gov
[2] Rapid Onset of Renal Sympathetic Nerve Activation in Rabbits Fed a High-Fat Diet
Armitage, James A.
Burke, Sandra L.
Prior, Larissa J.
Barzel, Benjamin
Eikelis, Nina
Lim, Kyungjoon
Head, Geoffrey A.
[J]. HYPERTENSION, 2012, 60 (01) : 163 - 171
[3] Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial
Azizi, Michel
Saxena, Manish
Wang, Yale
Jenkins, J. Stephen
Devireddy, Chandan
Rader, Florian
Fisher, Naomi D. L.
Schmieder, Roland E.
Mahfoud, Felix
Lindsey, Jason
Sanghvi, Kintur
Todoran, Thomas M.
Pacella, John
Flack, John
Daemen, Joost
Sharp, Andrew S. P.
Lurz, Philipp
Bloch, Michael J.
Weber, Michael A.
Lobo, Melvin D.
Basile, Jan
Claude, Lisa
Reeve-Stoffer, Helen
McClure, Candace K.
Kirtane, Ajay J.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (08): : 651 - 661
[4] Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial
Azizi, Michel
Sanghvi, Kintur
Saxena, Manish
Gosse, Philippe
Reilly, John P.
Levy, Terry
Rump, Lars C.
Persu, Alexandre
Basile, Jan
Bloch, Michael J.
Daemen, Joost
Lobo, Melvin D.
Mahfoud, Felix
Schmieder, Roland E.
Sharp, Andrew S. P.
Weber, Michael A.
Sapoval, Marc
Fong, Pete
Pathak, Atul
Lantelme, Pierre
Hsi, David
Bangalore, Sripal
Witkowski, Adam
Weil, Joachim
Kably, Benjamin
Barman, Neil C.
Reeve-Stoffer, Helen
Coleman, Leslie
McClure, Candace K.
Kirtane, Ajay J.
[J]. LANCET, 2021, 397 (10293) : 2476 - 2486
[5] Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
Azizi, Michel
Schmieder, Roland E.
Mahfoud, Felix
Weber, Michael A.
Daemen, Joost
Davies, Justin
Basile, Jan
Kirtane, Ajay J.
Wang, Yale
Lobo, Melvin D.
Saxena, Manish
Feyz, Lida
Rader, Florian
Lurz, Philipp
Sayer, Jeremy
Sapoval, Marc
Levy, Terry
Sanghvi, Kintur
Abraham, Josephine
Sharp, Andrew S. P.
Fisher, Naomi D. L.
Bloch, Michael J.
Reeve-Stoffer, Helen
Coleman, Leslie
Mullin, Christopher
Mauri, Laura
[J]. LANCET, 2018, 391 (10137) : 2335 - 2345
[6] Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial
Bhatt, Deepak L.
Vaduganathan, Muthiah
Kandzari, David E.
Leon, Martin B.
Rocha-Singh, Krishna
Townsend, Raymond R.
Katzen, Barry T.
Oparil, Suzanne
Brar, Sandeep
DeBruin, Vanessa
Fahy, Martin
Bakris, George L.
[J]. LANCET, 2022, 400 (10361) : 1405 - 1416
[7] A Controlled Trial of Renal Denervation for Resistant Hypertension
Bhatt, Deepak L.
Kandzari, David E.
O'Neill, William W.
D'Agostino, Ralph
Flack, John M.
Katzen, Barry T.
Leon, Martin B.
Liu, Minglei
Mauri, Laura
Negoita, Manuela
Cohen, Sidney A.
Oparil, Suzanne
Rocha-Singh, Krishna
Townsend, Raymond R.
Bakris, George L.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (15) : 1393 - 1401
[8] Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
Bohm, Michael
Kario, Kazuomi
Kandzari, David E.
Mahfoud, Felix
Weber, Michael A.
Schmieder, Roland E.
Tsioufis, Konstantinos
Pocock, Stuart
Konstantinidis, Dimitris
Choi, James W.
East, Cara
Lee, David P.
Ma, Adrian
Ewen, Sebastian
Cohen, Debbie L.
Wilensky, Robert
Devireddy, Chandan M.
Lea, Janice
Schmid, Axel
Weil, Joachim
Agdirlioglu, Tolga
Reedus, Denise
Jefferson, Brian K.
Reyes, David
D'Souza, Richard
Sharp, Andrew S. P.
Sharif, Faisal
Fahy, Martin
DeBruin, Vanessa
Cohen, Sidney A.
Brar, Sandeep
Townsend, Raymond R.
[J]. LANCET, 2020, 395 (10234) : 1444 - 1451
[9] Resistant Hypertension An Update of Experimental and Clinical Findings
Cai, Anping
Calhoun, David A.
[J]. HYPERTENSION, 2017, 70 (01) : 5 - 9
[10] Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
Carey, Robert M.
Calhoun, David A.
Bakris, George L.
Brook, Robert D.
Daugherty, Stacie L.
Dennison-Himmelfarb, Cheryl R.
Egan, Brent M.
Flack, John M.
Gidding, Samuel S.
Judd, Eric
Lackland, Daniel T.
Laffer, Cheryl L.
Newton-Cheh, Christopher
Smith, Steven M.
Taler, Sandra J.
Textor, Stephen C.
Turan, Tanya N.
White, William B.
[J]. HYPERTENSION, 2018, 72 (05) : E53 - E90

← 1 2 3 4 →